Bhupendra Singh takes over as new NPPA chairman

New Delhi

Bhupendra Singh, an IAS officer of 1985 cadre from Uttar Pradesh has taken over as the new chairman of National Pharmaceutical Pricing Authority (NPPA). He has earlier served as the principal secretary, govt. of Uttar Pradesh, divisional commissioner of Meerut, secretary general of a UN sponsored International Jute Study Group based in Dhaka and also joint secretary, textiles, government of India. Before Bhupendra Singh took over as the NPPA chairman, Injeti Srinivas who was holding the additional charge of chairman of NPPA, has taken over as the new director general of Sports Authority of India (SAI). A 1983 cadre IAS officer from Odisha cadre, Srinivas is a graduate in economics and masters in business administration. NPPA has been established through a government of India resolution on August 29, 1997, and is responsible for the implementation of the National Pharmaceutical Pricing Policy, 2012 and the New Drugs (Prices) Control Order (DPCO), 2013.
National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India and availability of the medicines in the country, under the Drugs (Prices Control) Order, 1995.The organization is also entrusted with the task of recovering amounts overcharged by manufacturers for the controlled drugs from the consumers. It also monitors the prices of decontrolled drugs in order to keep them at reasonable levels. As an independent regulator of drug price in the country, the NPPA is currently guided by the DPCO 2013, which provides for a market based pricing mechanism as opposed a cost based pricing mechanism that was prevalent under DPCO 1995

  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices